EX-FILING FEES 2 ny20020700x2_ex107.htm FILING FEES TABLE
Exhibit 107

 
Calculation of Filing Fee Tables
 
424(b)(5)
(Form Type)

 
Bristol-Myers Squibb Company
(Exact Name of Registrant as Specified in its Charter)

 
Table 1: Newly Registered and Carry Forward Securities
 
                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Security
Type
 
Security
Class
Title
 
Fee
Calculation
or Carry
Forward
Rule(1)
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
 
Carry
Forward 
Form
Type
 
Carry
Forward 
File
Number 
 
Carry
Forward 
Initial
Effective 
Date
 
Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to
be Carried
Forward
 
Newly Registered Securities
                                                 
Fees to Be Paid
 
Debt
 
Floating Rate Notes due 2026
 
Rule 457(r)
 
$500,000,000
 
100.000%
 
$500,000,000
 
0.00014760
 
$73,800.00
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
4.950% Notes due 2026
 
Rule 457(r)
 
$1,000,000,000
 
99.948%
 
$999,480,000
 
0.00014760
 
$147,523.25
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
4.900% Notes due 2027
 
Rule 457(r)
 
$1,000,000,000
 
99.892%
 
$998,920,000
 
0.00014760
 
$147,440.59
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
4.900% Notes due 2029
 
Rule 457(r)
 
$1,750,000,000
 
99.790%
 
$1,746,325,000
 
0.00014760
 
$257,757.57
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
5.100% Notes due 2031
 
Rule 457(r)
 
$1,250,000,000
 
99.843%
 
$1,248,037,500
 
0.00014760
 
$184,210.34
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
5.200% Notes due 2034
 
Rule 457(r)
 
$2,500,000,000
 
99.977%
 
$2,499,425,000
 
0.00014760
 
$368,915.13
 
  
 
  
 
  
 
 
                                                 
Fees to Be Paid
 
Debt
 
5.500% Notes due 2044
 
Rule 457(r)
 
$500,000,000
 
99.245%
 
$496,225,000
 
0.00014760
 
$73,242.81
 
              
                                                 
Fees to Be Paid
  
Debt
  
5.550% Notes due 2054
  
Rule 457(r)
  
$2,750,000,000
  
99.609%
  
$2,739,247,500
  
0.00014760
  
$404,312.93
                
                                                 
Fees to Be Paid
  
Debt
  
5.650% Notes due 2064
  
Rule 457(r)
  
$1,750,000,000
  
99.575%
  
$1,742,562,500
  
0.00014760
  
$257,202.23
                
                                                 
Fees Previously Paid
  
N/A
  
N/A
  
N/A
  
N/A
  
N/A
  
N/A
      
N/A
                
 
Carry Forward Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Carry Forward Securities
 
N/A
 
N/A
 
N/A
 
N/A
 
  
 
N/A
 
  
 
  
 
N/A
 
N/A
 
N/A
 
N/A
 
 
 
 
  
 
 
 
 
 
 
 
Total Offering Amounts 
 
  
 
$12,970,222,500
 
  
 
$1,914,404.84
 
  
 
  
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Total Fees Previously Paid 
 
  
 
  
 
  
 
—
 
  
 
  
 
  
 
 
 
 
 
 
    
 
 
 
 
 
 
Total Fee Offsets 
 
  
 
  
 
  
 
—
 
  
 
  
 
  
 
 
 
 
 
    
 
 
 
 
 
 
 
Net Fee Due 
 
 
 
 
 
 
 
$1,914,404.84
 
 
 
 
 
 
 
 

(1)
In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), Bristol-Myers Squibb Company (the “Company”) initially deferred payment of all registration fees for the Registration Statement on Form S-3 (Registration No. 333-261623), filed on December 13, 2021. This filing fee exhibit is in connection with a final prospectus supplement dated February 14, 2024, filed by the Company with the SEC pursuant to Rule 424(b) of the Securities Act.